Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
June 19, 2016
Respiratory viruses in young South African children with acute lower respiratory infections and interactions with HIV
Alicia A Annamalay, Salome Abbott, Chisha Sikazwe, et al.
Vaccine
|
July 21, 2023
Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial
Tilda Orami, Celestine Aho, Rebecca L Ford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2018
Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants
William S Pomat, Anita H J van den Biggelaar, Sandra Wana, et al.
The Journal of Allergy and Clinical Immunology
|
June 9, 2009
Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations
Anita H J van den Biggelaar, Susan L Prescott, Marjut Roponen, et al.
The Pediatric Infectious Disease Journal
|
April 7, 2012
Prevalence of and risk factors for human rhinovirus infection in healthy aboriginal and non-aboriginal Western Australian children
Alicia A Annamalay, Siew-Kim Khoo, Peter Jacoby, et al.
Pneumonia (Nathan Qld.)
|
January 5, 2018
Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
Deborah Lehmann, Wendy Kirarock, Anita H J van den Biggelaar, et al.
Clinical and Vaccine Immunology : CVI
|
September 25, 2009
Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants
Jacinta P Francis, Peter C Richmond, William S Pomat, et al.
BMJ Open
|
May 26, 2020
10-Valent pneumococcal non-typeable <i>H. influenzae</i> protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
Victor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
International Journal of Audiology
|
September 11, 2023
Ear and hearing outcomes in Aboriginal infants living in an urban Australian area: the <i>Djaalinj Waakinj</i> birth cohort study
Tamara Veselinović, Sharon A Weeks, Valerie M Swift, et al.
The Pediatric Infectious Disease Journal
|
December 23, 2011
Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy
Anita H J van den Biggelaar, William S Pomat, Suparat Phuanukoonnon, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
June 19, 2016
Respiratory viruses in young South African children with acute lower respiratory infections and interactions with HIV
Alicia A Annamalay, Salome Abbott, Chisha Sikazwe, et al.
Vaccine
|
July 21, 2023
Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial
Tilda Orami, Celestine Aho, Rebecca L Ford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2018
Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants
William S Pomat, Anita H J van den Biggelaar, Sandra Wana, et al.
The Journal of Allergy and Clinical Immunology
|
June 9, 2009
Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations
Anita H J van den Biggelaar, Susan L Prescott, Marjut Roponen, et al.
The Pediatric Infectious Disease Journal
|
April 7, 2012
Prevalence of and risk factors for human rhinovirus infection in healthy aboriginal and non-aboriginal Western Australian children
Alicia A Annamalay, Siew-Kim Khoo, Peter Jacoby, et al.
Pneumonia (Nathan Qld.)
|
January 5, 2018
Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
Deborah Lehmann, Wendy Kirarock, Anita H J van den Biggelaar, et al.
Clinical and Vaccine Immunology : CVI
|
September 25, 2009
Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants
Jacinta P Francis, Peter C Richmond, William S Pomat, et al.
BMJ Open
|
May 26, 2020
10-Valent pneumococcal non-typeable <i>H. influenzae</i> protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
Victor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
International Journal of Audiology
|
September 11, 2023
Ear and hearing outcomes in Aboriginal infants living in an urban Australian area: the <i>Djaalinj Waakinj</i> birth cohort study
Tamara Veselinović, Sharon A Weeks, Valerie M Swift, et al.
The Pediatric Infectious Disease Journal
|
December 23, 2011
Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy
Anita H J van den Biggelaar, William S Pomat, Suparat Phuanukoonnon, et al.
Page
of 10